ARBOR PHARMS LLC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ARBOR PHARMS LLC, and what generic alternatives to ARBOR PHARMS LLC drugs are available?
ARBOR PHARMS LLC has four approved drugs.
There are three US patents protecting ARBOR PHARMS LLC drugs.
There is one patent family member on ARBOR PHARMS LLC drugs in one country and eleven supplementary protection certificates in ten countries.
Drugs and US Patents for ARBOR PHARMS LLC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-001 | Jan 29, 2016 | DISCN | Yes | No | 9,561,204 | ⤷ Sign Up | ⤷ Sign Up | ||||
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-001 | Jan 29, 2016 | DISCN | Yes | No | 9,427,421 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Arbor Pharms Llc | E.E.S. 200 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Arbor Pharms Llc | PEDIAMYCIN | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062304-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-002 | Jan 29, 2016 | DISCN | Yes | No | 8,747,894 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Arbor Pharms Llc | PEDIAMYCIN 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062304-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ARBOR PHARMS LLC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | 6,103,248 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Lotion | 0.5% | ➤ Subscribe | 2017-09-01 |
International Patents for ARBOR PHARMS LLC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2662077 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ARBOR PHARMS LLC Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1620113 | C 2015 036 | Romania | ⤷ Sign Up | PRODUCT NAME: IVERMECTINA; NATIONAL AUTHORISATION NUMBER: RO7674/2015/01, RO7674/2015/02, RO7674/2015/03, RO7674/2015/04, RO7674/2015/05; DATE OF NATIONAL AUTHORISATION: 20150526; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): MALTA MA117/01101; DATE OF FIRST AUTHORISATION IN EEA: 20150402 |
1620113 | C01620113/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: IVERMECTINUM; REGISTRATION NO/DATE: AUTORISATION SWISSMEDIC 65561 20.12.2016 |
1620113 | PA2015033 | Lithuania | ⤷ Sign Up | PRODUCT NAME: IVERMECTINUM; NAT. REGISTRATION NO/DATE: LT/1/15/3726/001 - LT/1/15/3726/005 20150513; FIRST REGISTRATION: MA117/01101 20150402 |
1620113 | CA 2015 00045 | Denmark | ⤷ Sign Up | PRODUCT NAME: IVERMECTIN, 22, 23-DIHYDROAVERMECTINB1A + 22,23-DIHRODROAVERMECTIN B1B FOR USE IN THE TREATMNET OF RESACEA; NAT. REG. NO/DATE: 54123 20150422; FIRST REG. NO/DATE: MT MA 117/01101 20150402 |
1620113 | 122015000079 | Germany | ⤷ Sign Up | PRODUCT NAME: IVERMECTIN ZU SEINER VERWENDUNG FUER DIE BEHANDLUNG VON ROSAZEA; NAT. REGISTRATION NO/DATE: 92429.00.00 20150429; FIRST REGISTRATION: MALTA MA 117/01101 20150402 |
1620113 | 15C0069 | France | ⤷ Sign Up | PRODUCT NAME: IVERMECTINE; NAT. REGISTRATION NO/DATE: NL 44511 20150721; FIRST REGISTRATION: MT - MA 117/01101 20150402 |
1620113 | 92915 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: IVERMECTINE POUR SON USAGE DANS LE TRAITEMENT DE LA ROSACEA; FIRST REGISTRATION: 20150402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.